pharma · Apnea of Prematurity · Safety and Pharmacokinetics
BELPHARMA
Belpharma s.a.
Belpharma is a pharma organization headquartered in LUXEMBOURG, LU. Primary therapeutic focus areas include Apnea of Prematurity, Safety and Pharmacokinetics. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s)
Luxembourg, LU HQ
2011 Founded
16 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Luxembourg, LU
- Founded
- 2011
- Employees
- 16
- Programs
- 3
- Drugs
- 2
- Patents
- 0
NPC-11 for intravenous or oral administration.
Phase 3 · small molecule · Apnea of Prematurity
NPC-11 for intravenous or oral administration. for Apnea of Prematurity is a Phase 3 program (small_molecule) at Belpharma s.a. with 1 ClinicalTrials.gov record(s).
Internal code NPC-11-1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Belpharma s.a.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Apnea of Prematurity
- Status
- completed
- Trials
- 1